Clinical Trials on Fracture Multiple in France

Total 1312 results

Institut de cancérologie Strasbourg Europe
Hôpitaux Universitaires de Strasbourg; GENTYANE (GEnoTYpage and sequencing...

Completed

Optical Genome Mapping in Characterization of Multiple Myeloma (MYELOPTIC)

Multiple Myeloma

France
Centre Hospitalier Universitaire de Nice
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Role of BCL-B in Multiple Myeloma

Multiple Myeloma

France
University Hospital, Toulouse
Takeda; Celgene

Terminated

Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma (IFM2014-03)

Multiple Myeloma

France
University Hospital, Toulouse

Unknown

"FU-IFM2009" Database Post IFM/DFCI 2009 Study (DB-FU-IFM2009)

Multiple Myeloma

France
Central Hospital, Nancy, France
University Hospital, Strasbourg, France; Centre Hospitalier Universitaire Dijon and other collaborators

Unknown

Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients (PROCOG-SEP)

Multiple Sclerosis | Cognitive Disorders

France
Hospices Civils de Lyon

Terminated

Visual Impairment, Oscillopsia and Multiple Sclerosis

Multiple Sclerosis

France
Centre Hospitalier Universitaire de Nice

Completed

Pre-operative Localization of Ground Glass Solitary Pulmonary Nodules (SLIDINGWIRE)

Lung Neoplasms

France
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
Centre Hospitalier Universitaire de la Réunion

Unknown

Incidence of Recall After Procedural Sedation With Propofol in the Emergency Department (MEMOPROPO)

Fractures Reduction | Joint Dislocation Reduction

France
Assistance Publique - Hôpitaux de Paris

Completed

A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients (REHABMUSCLE)

Multiple Sclerosis

France
Pôle Saint Hélier
University Hospital, Angers; Rennes University Hospital; Université Européenne...

Completed

Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis (COGNISEP)

Multiple Sclerosis | Social Cognition | Theory of Mind | Neuropsychology | Psychological Therory

France
Nantes University Hospital

Recruiting

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma in First Line Treatment (PentiMyelo)

Multiple Myeloma

France
University Hospital, Caen

Recruiting

Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma (IDARA)

Multiple Myeloma

France
Assistance Publique Hopitaux De Marseille

Completed

Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients (MYELOME-MM)

Multiple Myeloma

France
Rennes University Hospital

Completed

Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression (IMMUNO-MYELO)

Multiple Myeloma

France
University Hospital, Toulouse
Celgene; Onyx Therapeutics, Inc.

Unknown

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction (IFM-CRd)

Multiple Myeloma

France
AB Science

Completed

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

Multiple Myeloma

France
University Hospital, Caen
H. Lundbeck A/S; Ministry of Health, France

Completed

Study on Cognitive Disorders of Multiple Sclerosis

Multiple Sclerosis

France
Institut Jerome Lejeune
Fondation Jérôme Lejeune

Completed

Correlations Phenotype / Genotype in Down Syndrome (INTREPID)

Down Syndrome

France
Centre René Gauducheau

Completed

Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 (BB4)

Multiple Myeloma

France
Nantes University Hospital

Terminated

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

Multiple Myeloma

France
University Hospital, Lille

Completed

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Multiple Myeloma

France
Nantes University Hospital

Terminated

Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

France
Institut Jerome Lejeune

Recruiting

Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin (BioJeL)

Intellectual Disability | Down Syndrome

France
Institut Jerome Lejeune
Hôpital Armand Trousseau

Completed

Anomalies of Nocturnal Gaz Exchanges in Patients With Down Syndrome

Down Syndrome

France
Paris Nanterre University
Isfahan University of Medical Sciences

Unknown

Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis

Anxiety

France
Institut Jerome Lejeune
Fondation Jérôme Lejeune

Completed

Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome

Down Syndrome

France
EDMUS Foundation

Recruiting

OFSEP Very High Definition Cohort (VHD cohort)

Multiple Sclerosis

France
University Hospital, Limoges

Recruiting

Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home Setting (Carfil-HAD)

Hematological Diseases

France
Pierre and Marie Curie University

Completed

Effect of Need to Void on Gait Speed in Multiple Sclerosis

Multiple Sclerosis | Lower Urinary Tract Symptoms | Gait

France
Nantes University Hospital

Completed

Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP) (CARMYSAP)

Myeloma

France
Hospices Civils de Lyon

Completed

Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning (IFM 2005-03)

Myeloma

France
Groupe Hospitalier Pitie-Salpetriere
Institut National de la Santé Et de la Recherche Médicale, France

Unknown

Sleep Disorders in Patients With Multiple Sclerosis

Multiple Sclerosis

France
Centre Hospitalier Universitaire de Nīmes

Completed

Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients (CalciCoach)

Multiple Sclerosis

France
Rennes University Hospital

Completed

Preventive Use of COrticosteroids During the Post-Partum in Relapsing MS Patients (COPP-MS) (COPP-MS)

Multiple Sclerosis

France
Kessler Foundation
National Multiple Sclerosis Society

Completed

Intellectual Enrichment to Build Cognitive Reserve in MS

Cognitive Impairment in Multiple Sclerosis

United States
Biogen

Completed

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) (REFINE)

Relapsing-Remitting Multiple Sclerosis

France, Italy, Spain, Germany, Belgium
Biogen

Terminated

Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants (REVEAL)

Relapsing-Remitting Multiple Sclerosis

United States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
Centre Leon Berard
National Cancer Institute, France

Recruiting

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70. (PASCA -MM)

Multiple Myeloma | Complication

France
Institut De La Colonne Vertebrale Et Des Neurosciences

Completed

Exopulse Mollii Suit, Spasticity & Tissue Oxygenation (ENNOX)

Multiple Sclerosis

France
Poitiers University Hospital
Sanofi; Intergroupe Francophone du Myelome

Active, not recruiting

Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).

Multiple Myeloma | Myeloma

France
Assistance Publique - Hôpitaux de Paris

Completed

French Kabuki Syndrome Network. Epidemiology, Management of Patients and Research by Array-CGH (Kabuki)

Kabuki Syndrome

France
Assistance Publique - Hôpitaux de Paris
ARSEP (Association pour la Recherche sur la Sclerose en Plaques); JNLF (Journées...

Completed

Early Cognitive Impairment in Multiple Sclerosis (CogniSEP)

Multiple Sclerosis | Cognitive Impairment

France
Fondation Ophtalmologique Adolphe de Rothschild

Completed

3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON) (FLACON)

Multiple Sclerosis | Optic Neuritis | Encephalopathy

France
Centre Henri Becquerel

Recruiting

Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma (SOSAM)

Multiple Myeloma

France
Assistance Publique - Hôpitaux de Paris
Intergroupe Francophone du Myelome

Recruiting

Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care (AMBROBiMM)

Multiple Myeloma

France
Bristol-Myers Squibb

Active, not recruiting

Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel (ABE-DESCART)

Multiple Myeloma

France
University Hospital, Montpellier

Terminated

Self-management of Type 1 Diabetes Under Functional Insulin Therapy (EVAUTODIAB)

Type 1 Diabetes | Basal-bolus Multiple-dily Insulin Injections | Insulin Pump (CSII)

France
Assistance Publique - Hôpitaux de Paris

Completed

"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival (EVALICEMM)

Multiple Myeloma

France
Assistance Publique - Hôpitaux de Paris

Withdrawn

Daratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 Trial (DARALLO)

Multiple Myeloma

France

3

Subscribe